Loteprednol Etabonate And Tobramycin Suspension/ Drops
Product Images NDC 46708-801
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate And Tobramycin (NDC 46708-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Loteprednol-tobra-bottle-10ml-ltd (Loteprednol Tobra Bottle 10ml Ltd)
Description: The text provides information about a medication called "EschmL" that contains active ingredients such as Loteprednol Etabonate (0.5%) and Tobramycin (0.3%). The usual dosage is not available, and the storage instructions indicate storing at room temperature between 15-25°C (53-77°F) and to protect from freezing. The manufacturer is mentioned as Alembic Pharmaceuticals Limited in India. The product is an ophthalmic suspension for eye use only, provided in a 10mL sterile container. Additional details include the NDC number, lot number, expiration date, and instructions to shake vigorously before use and use only with the provided cap.*
Loteprednol-tobra-bottle-5ml-ltd (Loteprednol Tobra Bottle 5ml Ltd)
Loteprednol-tobra-carton-10ml-ltd (Loteprednol Tobra Carton 10ml Ltd)
Loteprednol-tobra-carton-5ml-ltd (Loteprednol Tobra Carton 5ml Ltd)
This text appears to be a description for a medication product. The product contains Loteprednol Etabonate 5 mg (0.5%) and Tobramycin 3 (0.3%) in the form of an ophthalmic suspension. It is recommended to be stored upright and out of reach of children. The prescription should be used before the expiration date and the product is meant for eye use only. The product should be shaken vigorously before use and the ring on the container should be intact. Please ensure to follow the instructions provided on the label before using the medication.*
Loteprednol-tobra-structure (Loteprednol Tobra Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.